StockWatch
·
Farming/Seeds/Milling
Business UpdateJul 13, 2026, 07:41 AM

Origin Agritech Details Turnaround, Biotech & Commercialization

AI Summary

Origin Agritech has outlined its strategic turnaround, led by CEO Weibin Yan, focusing on biotechnology and commercialization. The company achieved a significant milestone with the biosafety certificate for its BBL2-2 triple-stack GMO corn in May 2024 and received national recognition for its Hi3 gene-editing platform in December 2025. Origin Agritech is rebuilding its sales network, upgrading its supply chain, and aims to be among China's top five corn seed providers by 2029, with commercial production of GM seeds starting in 2025.

Key Highlights

  • BBL2-2 triple-stack GMO corn received biosafety certificate in May 2024.
  • Hi3 gene-editing platform recognized as a national breakthrough in December 2025.
  • CEO Weibin Yan invested personal capital and leads the strategic turnaround.
  • 1H FY2026 operating loss narrowed 47.8% year-over-year.
  • G&A expenses fell 70% year-over-year in 1H FY2026.
  • Commercial production of genetically modified seeds commenced in 2025.
  • Received over $1M in pre-sales down payments for new varieties.
  • Aims to rank among China's top five corn seed providers by 2029.